The maker of Adderall, Pennsylvania-based Shire Pharmaceuticals, has settled a whistleblower suit for $56.5 million in the Eastern District of Pennsylvania.
Dr. Gerardo Torres—who had been an executive at Shire—originally brought claims against the company under the federal False Claims Act in 2008.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]